Premium
Diabetic retinopathy
Author(s) -
BANDELLO F
Publication year - 2011
Publication title -
acta ophthalmologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.534
H-Index - 87
eISSN - 1755-3768
pISSN - 1755-375X
DOI - 10.1111/j.1755-3768.2011.4315.x
Subject(s) - diabetic macular edema , medicine , diabetic retinopathy , ophthalmology , diabetes mellitus , retinal , thickening , macular edema , retinopathy , intervention (counseling) , optometry , intensive care medicine , endocrinology , chemistry , psychiatry , polymer science
Diabetic macular edema (DME), defined as a retinal thickening involving or approaching the centre of the macula, represents the most common cause of vision loss in patients affected by diabetes mellitus. The pathogenesis and the course of the DME requires a complex approach with multidisciplinary intervention both at systemic and local level. In the last few years many diagnostic tools have been proved useful in the detection and the monitoring of the features characterizing DME. At the same time, several therapeutic approaches can now be proposed on the basis of the DME specific characteristics. Aim of the present chapter is to thoroughly outline the clinical and morpho‐functional characteristics of DME and its current treatment perspectives. More specifically, each DME subtype can be successfully managed making the most of the current treatment paradigm, including laser treatment, intravitreal steroids and anti‐VEGF, and macular surgery.